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Abstract
Pre-clinical animal models play a crucial role in the translation of biomedical technologies from 
the bench top to the bedside. However, there is a need for improved techniques to evaluate 
implanted biomaterials within the host, including consideration of the care and ethics associated 
with animal studies, as well as the evaluation of host tissue repair in a clinically relevant manner. 
This review discusses non-invasive, quantitative, and real-time techniques for evaluating host-
materials interactions, quality and rate of neotissue formation, and functional outcomes of 
implanted biomaterials for bone and cartilage tissue engineering. Specifically, a comparison will 
be presented for pre-clinical animal models, histological scoring systems, and non-invasive 
imaging modalities. Additionally, novel technologies to track delivered cells and growth factors 
will be discussed, including methods to directly correlate their release with tissue growth.
Keywords
Cell tracking; histological scoring; imaging; non-destructive; non-invasive
I. Introduction
In bone and articular cartilage tissue engineering, there are three primary goals in mind for 
treatment: 1) repair damaged tissue, 2) restore function of damaged articular surface or bone, 
and 3) fully regenerate the morphological and functional properties of the affected region 
using the host biological response.62 Currently, the efficacy of implanted biomaterials to 
fulfill these goals can only be validated by in vitro testing followed by implantation in pre-
clinical animal models.122 The use of animal models provides a more clinically relevant 
approach as compared to in vitro techniques by simulating the dynamic and complex in vivo 
bone and cartilage microenvironment, providing a standardized metric for quantifying 
biomaterial performance, and allowing clinically-relevant predictions of therapeutic 
efficacy. A number of animal models have been established and assessed for bone and 
articular cartilage tissue engineering based on species, defect size and site, surgical 
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procedure, and implantation period, which has been discussed in other 
reviews.22, 59, 61, 85, 104 While animal models are reflective of the human population, 
translational outcomes are dependent upon the species and tissue type, in which variability 
and model selection can bias results.
Evaluation of repair outcomes is most commonly limited to discrete time points using 
histology and mechanical testing, which are invasive, require large animal sample sizes, and 
provide indirect and qualitative information on the mechanisms and quality of repair by the 
implanted biomaterial. It would be ideal to develop technologies with equal diagnostic 
power but minimal surgical invasion, especially with the ability to provide a clear picture of 
the total defect healing and integration with host tissue. This may include real-time 
evaluation of bone and articular cartilage repair with the intent to provide diagnostic 
indicators of disease progression. In general, the evaluation of tissue in a non-invasive, real-
time manner would allow a better understanding of repair and growth in a continuous time-
scale. Techniques described in this review will include recent progress on the following 
topics: functional mechanical testing of implants, histological scoring systems, imaging 
modalities, and growth factor and cell tracking in animal models.
III. In vivo characterization of biomaterials for bone and cartilage repair
The development of diagnostic tools for quantifying functional outcomes of therapeutic 
repair is important for translation from animal models to the clinic. Biomaterial performance 
in vivo is based on metrics that evaluate mechanical, biochemical, and biological changes, 
including material breakdown, host remodeling, and neotissue growth. Standards for strict 
evaluation of tissue engineered constructs, particularly in defect models, can be found in 
Table 1. This section will introduce modalities of functional biomaterial testing in vivo using 
mechanical testing, histological scoring, and imaging, with a specific focus on non-invasive, 
real-time methods. A summary of select studies and their various modes of evaluation can 
be found in Table 2.
A. Mechanical testing of bone and cartilage implants
While the mechanical characterization of bone has been well-established for preclinical 
studies,3 functional testing of cartilage has yet to be fully characterized due to the inability 
to fully regenerate the damaged tissue.63 Furthermore, mechanical tests to assess the shear, 
tensile and compressive properties of engineered cartilage have been typically destructive. 
Indentation testing is a type of compressive test that offers a potential technique for in situ, 
non-destructive mechanical analysis of cartilage, and has been used in conjunction with 
arthroscopy and imaging techniques such as computed tomography, ultrasound (US), 
magnetic resonance spectroscopy, and x-ray to quantify characteristics such as the dynamic 
mechanical modulus,6, 18, 73 cartilage thickness,6, 18, 73 stiffness,6, 46, 84, 120 and 
degeneration.6, 18 Although in many of these accounts indentation testing was performed on 
harvested tissue, which does not directly demonstrate in vivo diagnostic capabilities for 
clinical translation, work is continually being done to minimize the invasiveness of this 
procedure to improve mechanical analysis and understanding of cartilage repair and 
degeneration. Design considerations for minimizing the invasiveness include the size and 
geometry of the indenter,84 since direct contact with the native cartilage may cause abrasion 
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of the surface.10 For improvement of diagnostic efficiency, the reproducibility of the 
measured mechanical forces (of an indentation probe) or output signals (in the case of 
imaging modalities) is important,18 especially for user and machine variability. However, 
fixtures may be designed to reproducibly position the instrument to minimize user 
variability, which has been demonstrated with an US device used to couple acoustics with 
mechanical properties.125 Additionally, measurements may vary depending on the 
penetration depth of the indenter, so appropriate thresholds should be established before 
testing.84 An alternative to contact indentation to consider is water jet indentation, which 
uses water instead of a physical probe for mechanical measurement, and has been evaluated 
in tissue phantoms, ex vivo plugs, and a rabbit osteoarthritis model with favorable 
correlation to contact indentation.80, 127 However, more validation is needed before this can 
be widely adapted.
Indentation testing can also be improved in combination with other techniques to assess 
cartilage quality in addition to mechanical measurements. By applying electric fields, 
electrokinetic measurements can be obtained by detection of current induced-stress gradients 
that sensitively correlate to changes in the cartilage composition,101, 133 and ultimately, 
changes to cartilage health. A promising non-invasive technique that uses this approach and 
currently being investigated is electroarthrography.99 The electrochemical properties of 
cartilage such as fixed charged density can also be obtained by using indentation testing 
with biphasic and triphasic analyses.81
Despite the advantages of indentation testing, one must consider that the mechanical 
properties of the cartilage are site-dependent, differing in load-bearing or non-load-bearing 
sites.46 Models of indentation testing have been introduced to account for cartilage 
anisotropy,66 but the validity of these models depends on the quality of the indentation data. 
Additionally, at the moment, indentation testing provides little information on the 
mechanical properties of the radial zone of cartilage or the bone-cartilage interface. 
Therefore, while severe mechanical injury of cartilage may be detectable with this non-
destructive method, the difficulty of detecting varying degrees of minor injury continues to 
be a challenge for both small animal models and diagnosis in the clinic, and has not yet been 
standardized for functional testing of cartilage. However, the combination of indentation 
testing, histology, and, particularly imaging, may play an important role in validating the 
diagnostic capacity of each tool separately.120
B. Evaluating biomaterial-host interactions with histological scoring
Histological staining allows for the qualitative evaluation of bone and cartilage tissue 
microarchitectures with high spatial resolution, morphological fidelity, and specificity with 
different stains (Table 3). However, when examining histological samples at discrete time 
points, it is challenging to make quantitative and statistically powered statements regarding 
tissue development and therapeutic efficacy. Thus, histomorphometric scoring methods 
provide a means for semi-quantitative analysis of bone and cartilage histology samples.
The nomenclature, metrics, and methods for bone histomorphometry were standardized in 
1987,94 and updated in 2012.36 Bone histomorphometry focuses on four main metrics: area, 
length, distance, and number. When adapted for bone tissue engineering, these metrics 
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provide an assessment of the performance and bone regenerative capacity of a tissue 
engineering construct in terms of the scaffold degradation, scaffold mineralization and 
material biocompatibility, and tissue/cell types and number present and volume, surface 
area, union and thickness of neotissue, respectively.36 Since there are no standardized global 
scoring systems for bone, the combination of parameters for histological analysis depend on 
the defect model, slicing location and direction, and histological stains used.
Unlike bone, the success of tissue engineered cartilage is based primarily on quality of 
cartilaginous neotissue, making histomorphometric analysis an important measure of 
outcome. Various osteochondral scoring systems have been established to evaluate the 
quality of the repair tissue as a whole after implantation of a biomaterial, including: repair 
tissue thickness and type, cell population and distribution, ECM, and subchondral bone 
filling, morphology, and type.82, 91 Commonly used scoring systems include the O’Driscoll 
score88 and Bern score,105 which have been validated and refined in a number of defect 
models.14, 57, 97 Other systems such as the Outerbridge score, Oswestry Arthroscopy Score 
(OAS), and International Cartilage Repair Society (ICRS) scoring of cartilage have been 
established to classify the severity of the lesion and depth with respect to the subchondral 
bone, as well as the natural ability of the defect to repair itself.116 The variety of scoring 
systems for cartilage evaluation presents questions as to which scoring systems may be 
validated appropriately for specific applications and will provide useful data for further 
comparison.105 While it is difficult to determine if the same scoring system should be valid 
for scaffolds implanted in different locations of the knee joint (femoral condyle, 
patellofemoral groove32), simplicity is preferred over customization for each case.105 Before 
choosing a scoring system, however, it is important to assess its validity in previous 
experiments and its relevance to the anatomy and physiology of the animal model under 
investigation.
Ultimately, histomorphometric scoring systems are important measures of outcome for in 
vivo repaired bone and cartilage tissue, but the globally derived scalar value provides only a 
semi-quantitative and subjective assessment. To improve this, an appropriate statistical 
analysis, increased quantification of histological samples, and better metrics for repair must 
be considered. Scoring systems are generally non-parametric and require appropriate 
statistics to account for non-quantitative data.58, 71, 95 Although image analysis is not a new 
concept,83 advances in computer technology and computing power provide new and 
automated methods for quantifying tissue growth and scaffold behavior in two-dimensional 
(2D) histological samples, which warrant further investigation.51, 111 Additionally, scoring 
systems using non-invasive imaging such as micro-computed tomography (microCT),15,53 
magnetic resonance imaging (MRI), 85 US,106 or polarized light microscopy23 could be 
implemented to provide quantified measurements to complement histological data. For 
cartilage histology in particular, new modalities such as CT arthrography and MRI 
techniques such as delayed gadolinium-enhanced MRI of cartilage (dGEMRIC), T2 
mapping, T1rho mapping, ultra-short echo time (uTE), glycosaminoglycan (GAG)-specific 
chemical exchange saturation transfer (gagCEST), and sodium MRI enable monitoring of 
disease progression and engineered tissue formation through the quantification of GAGs, 
proteoglycans (PGs), and collagen content/orientation as imaging measures of outcome.89 
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Lastly, there is a need for improved metrics to assess bone and cartilage repair, including 
rates of growing tissues, proliferating cells, and decreasing void spaces; to differentiate 
between heterogeneous tissue samples; and to correlate to other outcome measures.48 The 
phenotype of cells, especially macrophages, has become a vital predictor in how the healing 
process will proceed and should be included in the measure of success as well.8, 19 
Similarly, when employing a disease, infection, or chronic injury in animal models, the use 
of clinically relevant tests of efficacy such as assessment of nociception, gait, and motor 
activity should be considered.42, 87 Increased consensus and standardization in regards to the 
adaptation of different scoring systems, parameters of measurement, and statistical analysis 
will enable improved comparison across studies to enhance efficacy of tissue engineered 
products.
C. Evaluating biomaterial interaction with imaging
When employing imaging modalities to evaluate in vivo response to implanted biomaterials, 
it is important to standardize methods in order to make quantifiable diagnostic conclusions 
about the biomaterial-host interactions and degree of tissue repair.15 It is also important to 
determine healthy baselines depending on the animal, since cartilage thickness and bone 
structure vary among species.22, 104 A comparison among several imaging modalities 
highlights some of the strengths in diagnostic detection of hard and soft tissue disease.4 It 
should be noted that while these modalities offer high resolution, 3D images of tissue, it is 
difficult to evaluate both bone and cartilage simultaneously in a nondestructive manner due 
to image contrast and interference of soft and hard tissues.98 Furthermore, visualization and 
distinction of biomaterials from tissue is still a challenge, and diagnostics of bone and 
cartilage repair often require validation from histological methods.
i. Magnetic Resonance Imaging (MRI)—MRI is a non-invasive imaging technique that 
employs strong magnetic fields and radiowaves to excite hydrogen atoms in the body, 
resulting in image contrast generated from the difference in longitudinal (T1) or transverse 
(T2) relaxation times of the atoms in different tissues. Due to lack of ionizing radiation or 
exogenous contrast agents and the advantage of high morphologic resolution, MRI has been 
employed together with histological scoring systems for bone and cartilage tissue 
engineering applications to enable semi-quantitative evaluation of bone growth and 
development, response to mechanical stimulus, structural integrity and fracture, and disease 
state, 15 as well as monitoring of cartilage disease progression and reconstruction in small 
animal models and clinically in human patients.98,50
Recent advances and validation in MRI techniques have provided new methods to 
accurately detect and quantify the biochemical composition of tissues. This is particularly 
promising for osteochondral tissue engineering, where GAGs, PGs, and collagen content/
orientation can be used as novel imaging biomarkers in addition to morphologic changes to 
evaluate cartilage and subchondral bone tissue degeneration and repair, as summarized in 
previous reviews.89 Techniques such as T1rho mapping, gagCEST, and sodium MRI enable 
contrast-free quantification of GAG and PG content through the correlation of T1rho 
relaxation times with bound water, or sodium signal intensity, to charged macromolecules in 
the cartilage ECM.17, 89 Similarly, dGEMRIC measures T1 relaxation times to provide an 
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indirect measurement and improved resolution of GAG content by utilizing the negative 
association between an administered negatively charged contrast agent and negatively 
charged GAG.50 As a complementary approach, T2 mapping can be used to reproducibly 
measure structural and content changes in the collagen matrix, which has been validated in a 
number of clinical studies.89 Although these techniques have great potential, beyond the 
general concerns regarding reproducibility, standardization of imaging parameters, and, for 
dGEMRIC, risks of contrast use, the correlation of these biomarkers to tissue ingrowth in 
biomaterial scaffolds has yet to be explored in great detail. In this manner, the imaging goal 
would be to detect an increase or improvement in biomechanical and physiologic function, 
as well as detect interactions between scaffold degradation and tissue repair. Additional 
consideration also is needed on how the material will contrast with the tissue and if this will 
cause interference during imaging.110
Regarding the cartilage-bone interface, several improvements have been made employing 
3D–spoiled gradient recalled echo imaging with fat suppression (3D–SPGR) and uTE to 
evaluate the osteochondral junction by using high field strengths and optimized pulse time 
echo sequences to measure the T1 and T2* (transverse relaxation detected in gradient-echo 
imaging)24 relaxation times, respectively.17, 50 Improvements have also been made in image 
contrast by taking advantage of fat saturation, water excitation, and changes in molecular 
charge present in the diseased tissue.9, 17 Although much has been done with uTE to detect 
the short T2/T2* relaxation times of the deep radial and calcified zones of cartilage,89 more 
investigations are needed to improve MRI techniques for evaluating tissue engineering 
strategies in animal models.115 This is especially important for translating preclinical results 
to human studies, since much higher magnetic fields are often needed to improve the SNR 
and resolution in small animals, but can be achieved with lower fields for similar diagnostic 
application in humans. However, animal studies must adhere to ethical safety and care 
guidelines with respect to possible field thresholds (to minimize tissue heating during 
imaging)44 and scan time, where appropriate. Fortunately, researchers have made efforts to 
standardize the sample preparation, calibration, scan parameters, and data analysis for 
consistent use of MRI.15
ii. Micro-computed tomography (microCT)—MicroCT is another commonly used 
imaging technique that provides high resolution and non-invasive visualization of bone and 
hard tissue, especially the microarchitecture, volume, surface area, tissue thickness and 
spatial distribution of mineralization. 117,123 MicroCT employs x-ray attenuation to create 
virtual slices of an object that can be reconstructed into an accurate 3D representation. Due 
to a low voxel size, microCT has arguably higher nominal resolution than MRI,7 allowing 
for additional visualization of vasculature and osteocyte morphology,117 degree of 
osteoconduction and bone ingrowth,128 as well as distinct phases of composite biomaterials 
in vivo.128 Moreover, imaging with microCT enables the characterization of scaffold 
integrity prior to and after implantation, including biphasic interfaces and tissue 
mineralization when the biomaterial comprises heterogeneous phases, such as polymer and 
ceramic components.109 Techniques have been implemented to approximate scaffold 
boundaries, cluster size distribution (scaffold and tissue phases), and pore size distribution 
with microCT.65 Additionally, microCT can also be used for in vivo imaging in small animal 
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models for longitudinal tracking of bone changes, although there are several concerns over 
prolonged radiation exposure, imaging duration, and movement artifacts that may be 
difficult for translation.16, 4715, 123 A detailed review on microCT evaluation of biomaterials 
for bone tissue engineering highlights some of the systems used, advances in the technology, 
and accuracy of 3D reconstructions.15, 112
However, microCT for cartilage assessment remains a challenge due to the lack of mineral 
components in soft tissues for intrinsic contrast.32 Advances in microCT contrast agents 
have enabled imaging and quantification of articular cartilage in small animals,115 and more 
recently, in large animal models and human patients.6, 15, 93, 115, 130 Termed contrast 
enhanced CT (CECT) or equilibrium partitioning of ionic contrast agent microCT (EPIC-
microCT), non-invasive imaging of cartilage morphology can be obtained through the 
inverse correlation of an ionic x-ray absorbing contrast agent with negatively charged PGs 
and GAGs, and has been demonstrated in humans118 and large animal models.6, 12, 76 With 
appropriate segmentation, even the cartilage-bone interface can be observed.
iii. Ultrasound (US)—US is another diagnostic technique that has been used to non-
invasively evaluate integrity of subchondral bone,54 tissue calcification,96 fluid content 
within the joint,124 synovial integrity,124 integrity of the cartilage-bone interface,106 
cartilage surface roughness,126 cartilage thickness,126 and cartilage disease state.52 US 
utilizes externally transmitted sound waves at a frequency of 2–15 MHz to generate 
structural and functional images in real-time from the mismatch in acoustic impedance in 
different living tissues.29 Several US systems and their various modes have been 
summarized in other reviews.29, 45 Efforts have been made to employ US as an alternative to 
biopsies and histological validation of stages of cartilage repair.53 Despite its ease of use, 
portability, safety, and non-invasiveness, US has primarily been used in humans and large 
animal models until recently due to issues with spatial and temporal resolution. Advances in 
computing and transducer technology have enabled high frequency US systems such as US 
biomicroscopy, which uses sound waves up to 100 MHz to achieve detailed images of 
articular cartilage and subchondral bone quality with micron scale resolution.29, 45 Although 
minimally invasive, another US technology, the intravascular US (IVUS) device, has been 
more frequently implemented in preclinical studies since it produces high-frequency images 
with high resolution through use of a catheter-based probe. By bypassing the superficial 
layers of skin and muscle, the IVUS can be used in conjunction with arthroscopy in 
osteochondral defects for improved assessment of cartilage thickness, composition, and 
structure.60, 67 However, the technology is limited in evaluating the underlying bone because 
it is not directly exposed to the surface and rapidly transmits sound. An additional limitation 
to consider is the possible intra-and inter-user variability that can drastically affect image 
quality such as the reproducible localization of focal lesions, posing challenges in repeatable 
quantification of articular cartilage and subchondral bone features.
D. Non-invasive tracking and monitoring
Despite advances in the current methods of in vivo analysis, there still remain significant 
challenges in correlating scaffold behavior and spatiotemporal delivery of stem cells or 
growth factors directly with tissue formation. Although neotissue growth and functional 
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restoration are ultimate indicators of efficacy, the development of tissue engineered 
constructs would benefit from non-invasive monitoring methods to understand of how 
delivered cells or biomolecules contribute to the regeneration process and compare their 
kinetics and performance to that of in vitro. The following section will provide brief 
discussion on technologies implemented for non-invasive and longitudinal tracking of stem 
cell activity, growth factor retention and kinetics, and scaffold degradation in vivo.
i. Fluorescent labeling—One of the most common cell tracking techniques is fluorescent 
labeling, which involves the binding or genetic expression of light-emitting fluorescent dyes 
or proteins to enable detection of cells using optical methods. Due to their use in pre-clinical 
oncology research, the breadth and scope of available dyes, reporters, and respective targets 
are extensive.100 This is useful in tissue engineering applications since delivered cells can be 
non-invasively tracked in real-time, allowing for observations regarding engraftment, 
survival, and tissue induction.77 Additionally, since the specificity of the fluorescent label 
can be tailored to different proteins within or outside cells and fluorescence can be coupled 
with other immunohistochemical probes and in vitro studies, mechanistic studies of cells 
including differentiation, secreted factors, chemotactic effects, and receptor-ligand 
interactions can be determined, even at the single cell level,1 to direct cellular migration and 
future remodeling within the defect site.
Using the red fluorescent dye PKH26, a number of studies have performed non-invasive, 
real-time tracking of transplanted mesenchymal stem cells (MSC) in a subcutaneous implant 
model, 131 as well as rabbit114 and minipig25 full thickness osteochondral model and sheep 
joint cavity model, 27 enabling longitudinal data regarding cell localization, viability, and 
chondrogenic differentiation for cartilage tissue engineering. However, there are a number 
of challenges for using fluorescence in vivo. Fluorescence is prone to photobleaching, 
leading to a varied duration of expression of reportedly 4–10 weeks,102, 114, 131, 132 and the 
resolution and depth of detection is limited by native tissue auto-fluorescence and 
attenuation, which makes fluorescence detection difficult in large animal models and 
orthotopic defects. Additionally, the signal is generally not quantifiable, since the 
fluorescence intensity is affected by the number of cells and their expression efficiency. 
Near-infrared fluorophores13, 30, 72 and other fluorescent nanoparticle systems39, 78 have 
been developed for improved depth detection and physicochemical stability, but require 
additional investigation due to detrimental effects to cells.39, 132
Through covalent binding of fluorophores directly to the biomaterial backbone, fluorescent 
labeling can also be used to monitor scaffold degradation kinetics and profile in vivo. The 
degradation of tetramethylrhodamine isothiocyanate (TRITC)-labeled chitosan membranes 
were successfully monitored in a subcutaneous mouse model for 2 weeks, and the measured 
fluorescence intensities correlated well with the weight loss of the implants.31 Membrane 
fragments were also observed in the neighboring tissue areas, allowing for monitoring of 
scaffold clearance. Comparisons have been made between in vitro and in vivo degradation 
kinetics of hydrolytically degradable fluorescein-tagged poly(ethylene glycol):dextran 
hydrogels and enzymatically degradable Texas Red-tagged collagen scaffolds.5 The in vivo 
degradation profiles closely correlated with those of in vitro, and differed depending on the 
location of the implant (subcutaneous, intraperitoneal, or muscle pocket). A number of other 
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fluorophores92 as well as imaging methods70, 134 have also been investigated, demonstrating 
the importance and challenges of developing a standard non-invasive method for monitoring 
scaffold degradation in vivo.
ii. Bioluminescent imaging—Similar to fluorescent labeling, bioluminescent imaging 
(BLI) enables the detection of cells through light emission, except that the light is generated 
through enzymatic cleavage of luciferin substrate by live cells.33 BLI procedures possess 
several advantages for tissue engineering applications, including long term expression up to 
21 months113 and enhanced signal-to-noise ratio due to low intrinsic bioluminescence in 
mammalian tissues.34 Two of the most common bioluminescent transgenic reporters are 
firefly luciferase (Photinus pyralis) and renilla luciferase (Renilla reniformis). Both 
reporters have been used for bone and cartilage tissue engineering to monitor and quantify 
cell migration, distribution, and proliferation in ectopic and orthotopic sites.34, 79, 90, 113 
Through reporter design with specific osteogenic or chondrogenic markers and dual 
bioluminescence labeling, cell differentiation through the changes in gene expression 
patterns can also be elucidated.11, 119 A detailed discussion of BLI transgenic reporters and 
potential applications specifically for bone tissue engineering can be found in other 
reviews.33
BLI still suffers from some of the limitations of fluorescence imaging, namely, the lack of 
penetration into hard tissues, and attenuation from neighboring tissue. Additionally, the 
bioluminescence intensity can be affected by tissue ingrowth into scaffolds and the scaffold 
material,2 and altered by the defect model11, 34 and method of luciferin administration 
(intravenous, subcutaneous, or intra-articular).113 Other considerations include the fact that 
since BLI requires living cells for light emission, implants post-harvest cannot be imaged 
with bioluminescence, and the transplanted cell population must be easily passaged without 
losing phenotype in order to obtain a homogenous bioluminescence expression.
iii. Radiolabeling—Radiolabeling is another tracking technique that involves the detection 
of decaying radioisotopes via nuclear imaging, scintillation, or gamma counter methods. 
Although some studies have explored its use for cell tracking49, 129 or scaffold 
biocompatibility,108 radiolabeling has been primarily used for monitoring growth factor 
kinetics, concentration, and bioactivity. Developments in non-invasive growth factor 
imaging with radiolabeling have commonly been examined in bone tissue engineering 
applications with iodine-125 (125I),35, 68 which has a half-life of 60 days and low energy 
emissions safe enough for biological tissues.40 Unlike fluorescence imaging or BLI, 
radiolabeling can provide quantifiable and more stable signals for in vivo monitoring 
without the need for ex vivo examination of implants at multiple time points. The release 
kinetics of 125I-labeled platelet-derived growth factor loaded in chitosan granules in a rat 
femur defect was successfully monitored weekly for 8 weeks using a probe-type gamma 
counter with collimator.35 Validation with in vitro delivery data and radioactivity 
measurements after harvest at each time point demonstrated close correlation with the non-
invasive data in terms of both kinetics and dose. By combining radioactivity measurements 
with radiographic and nuclear imaging techniques, both anatomical and functional 
information could be evaluated. It was demonstrated that 125I-labeled bone morphogenetic 
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protein-2 (BMP-2) in both ectopic and orthotopic sites could be monitored up to 8 weeks 
using scintillation probes, single photon emission computed tomography (SPECT), and 
microCT.69 125I-BMP-2 loaded within different biomaterial scaffolds was able to localize 
and promote bone regeneration at the defect site without observed differences in the 
regenerative performance of the BMP-2. Radiolabeling does have several drawbacks, 
however, including exposure to radiation, loss of tracer in vivo, and inaccurate 
measurements introduced by different labeling methods, detector position, and implant site. 
Detection of growth factor release from implanted carriers or into directly neighboring 
tissues is also limited due to poor resolution. Additionally, radiotracers and the sophisticated 
equipment required for detection can be costly, limiting their accessibility for widespread 
use. Despite these issues, the ability to sequentially track and correlate growth factor 
delivery with tissue regeneration is a powerful tool with potential applications in not just 
bone, but cartilage tissue engineering, where the controlled, spatiotemporal delivery of 
multiple growth factors is an increasingly employed strategy.121
iv. Magnetic particle labeling—Another well-established method for non-invasive in 
vivo imaging is the use of superparamagnetic iron oxide (SPIO) magnetic microparticles and 
nanoparticles as contrast agents for MRI.86 The particles consist of an iron oxide core with a 
surface coating to prevent aggregation and facilitate either cellular internalization or cell 
surface attachment.43 The particles can be detected through losses in signal intensity on T2-
weighted images via MRI with high spatial resolution. SPIO particles have been used in 
both cartilage and bone tissue engineering for cell tracking with detection periods up to 12 
weeks without significant alterations to cell viability.55, 64, 75, 103 However, aggregation of 
the particles remains a concern107 and some studies show that SPIO labeling may cause 
subtle differences in the differentiation capacities of labeled cells, resulting in altered ECM 
morphology.41 This suggests that even though SPIO technology has a long history in 
biomedical applications, its use in tissue engineering applications warrants further 
investigation regarding safety and cell function.
IV. Conclusion
In the recent years, advances in minimally invasive and non-destructive diagnostic 
technologies have provided powerful new tools by which bone and cartilage tissue 
engineering therapies can be comprehensively evaluated in vivo. In contrast to traditional 
histological staining and mechanical testing, non-invasive imaging and mechanical testing 
techniques such as microCT, MRI, US or indentation testing, novel pre-clinical models, and 
quantified histomorphometric scoring systems enable a clearer understanding of host-
material interactions and functional outcomes of implanted biomaterials on a continuous 
time-scale. Additionally, real-time in vivo monitoring via fluorescence imaging, BLI, or 
radiolabeling provides methods to directly differentiate in vitro and in vivo performance, 
correlate controlled delivery with neotissue formation, and elucidate the underlying 
mechanisms of cell and scaffold behavior. As these technologies are increasingly 
implemented and refined, there is a definite need for improved standardization and 
validation of their accuracy for comparisons across studies and significance in results. With 
any technique, the ability to visualize tissues and biological features with appropriate 
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resolution limits use in both small and large animal models. Limitations in penetration depth 
and localization of biomaterial implants and defect sites and instrument dimensions used for 
testing should be considered to achieve desired resolution. In order to improve resolution in 
small animals, strategies have been employed, such as the use of contrast (MRI, microCT, 
US) or higher magnetic fields (in the case of MRI) to reduce SNR, but these strategies may 
not be directly translatable to humans due to potentially associated cytotoxicities. 
Conversely, strategies that have been implemented for small animal models will require 
validation and optimization in order to successfully visualize host-biomaterial interactions in 
large animals and humans. In combination with the latest advancements in non-invasive in 
vitro techniques and 3D computational modeling, non-invasive and non-destructive 
diagnostic technologies offer improved assessment and supported conclusions regarding a 
tissue engineered construct’s efficacy and regenerative capacity in order to accelerate their 
translation to the clinic.
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125I Iodine-125
2D Two-dimensional
3D Three-dimensional
3D–SPGR Three-dimensional spoiled gradient recalled echo imaging with fat 
suppression
AB Alcian blue
BLI Bioluminescent imaging
BMP(−2,−7) Bone morphogenetic protein (−2,-7)
BSE Backscattered electron
CECT Contrast-enhanced computed tomography
DBM Demineralized bone matrix
dGEMRIC Delayed gadolinium enhanced magnetic resonance imaging of cartilage
ECM Extracellular matrix
EPIC-microCT Equilibrium partitioning of ionic contrast agent micro-computed 
tomography
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GAG Glycosaminoglycan
gagCEST Glycosaminoglycan-specific chemical exchange saturation transfer
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hAMSC Human adipose tissue-derived mesenchymal stem cells
hBMSC Human bone marrow stromal cells
hMSC Human mesenchymal stem cells
ICRS International Cartilage Repair Society
IHC Immunohistochemistry
ISO International Organization for Standardization
IVUS Intravascular ultrasound
Luc Luciferase
Trachtenberg et al. Page 19
Ann Biomed Eng. Author manuscript; available in PMC 2016 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
microCT Micro-computed tomography
MB Methylene blue
MP Microparticle
MRI Magnetic resonance imaging
MSC Mesenchymal stem cell
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ROI Region of interest
PCL Poly(ε-caprolactone)
PDGF Platelet-derived growth factor
PEG Poly(ethylene glycol)
PG Proteoglycan
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PIPAAm Poly(isopropylacrylamide)
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PLGA Poly(DL-lactic-co-glycolic acid)
PLLA Poly(L-lactic acid)
PPF Poly(propylene fumarate)
PVDF Poly(vinylidene difluoride)
RGD Arginylglycylaspartic acid
rhBMP-2 Human recombinant BMP-2
Saf O Safranin O
SEM Scanning electron microscopy
SNR Signal-to-noise ratio
SPECT Single photon emission computed tomography
SPIO Superparamagnetic iron oxide
TB Toluidine blue
TCP Tricalcium phosphate
TGF-β1 Transforming growth factor-β1
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TRITC Tetramethylrhodamine isothiocyanate
US Utrasound
uTE Ultra-short echo time
VG van Gieson
VK von Kossa
WK Working standard (ASTM)
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Table 1
Standards for Testing Implanted Biomaterials for Bone and Cartilage Tissue Engineering
Standard Title
ASTM 561 F Practice for Retrieval and Analysis of Medical Devices, and Associate Tissues and Fluids
ASTM 565 F Practice for Care and Handling of Orthopedic Implants and Instruments
ASTM 981 F Practice for Assessment of Compatibility of Biomaterials for Surgical Implants With Respect to Effect of Materials on 
Muscle and Bone
ASTM 1903 F Practice for Testing the Biological Responses to Particles in vivo
ASTM 1983 F Standard Practice for Assessment of Compatibility of Absorbable/Resorbable Biomaterials for Implant Applications
ASTM 2150 F Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Tissue-Engineered Medical Products
ASTM 2210 F Standard Guide for Processing Cells, Tissues, and Organs for Use in Tissue Engineered Medical Products
ASTM 2312 F Standard Terminology Relating to Tissue Engineered Medical Products
ASTM 2315 F Standard Guide for Immobilization or Encapsulation of Living Cells or Tissue in Alginate Gels
ASTM 2451 F Standard Guide for in vivo Assessment of Implantable Devices Intended to Repair or Regenerate Articular Cartilage
ASTM 2529 F Standard Guide for in vivo Evaluation of Osteoinductive Potential for Materials Containing Demineralized Bone
ASTM 2603 F Standard Guide for Interpreting Images of Polymeric Tissue Scaffolds
ASTM 2664 F Standard Guide for Assessing the Attachment of Cells to Biomaterial Surfaces by Physical Methods
ASTM 2721 F Standard Guide for Pre-clinical in vivo Evaluation in Critical Size Segmental Bone Defects
ASTM 2884 F Standard Guide for Pre-clinical in vivo Evaluation of Spinal Fusion
ASTM 2903 F Standard Guide for Tissue Engineered Medical Products for Reinforcement of Tendon and Ligament Repair
ISO 10993 Biological Evaluation of Medical Devices
WK16591 New Guide for Guide for the in vivo Assessment of Bone Inductive Materials
WK28852 New Guide for Pre-clinical in vivo Evaluation in Critical Size Metaphyseal Bone defects
WK31014 New Test Method for Standard Method using Goat for in vivo Testing Articular Cartilage Repair or Regeneration
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Table 3
Histological Stains for Evaluation of Bone and Cartilage Tissue
Stain Tissue/cell/ECM-color Application Reference
Alcian Blue (AB) Acid, mucins/ connective 
tissue
Blue Cartilage 26
Goldner’s trichrome (GT) Mineralized bone Blue Mineralized vs. non-mineralized tissue
20, 69
Osteoid Red
Nuclei Blue/ grey/ purple
Cartilage Purple
Hematoxylin & Eosin (H&E) Nuclei Blue Cellular organization
21, 69
Cytoplasm Pink/ red
Masson’s trichrome (MT) Muscle Red Connective tissue, mineralized vs. 
non-mineralized tissue
2, 37
Osteoid Blue/ green
Cytoplasm Red/pink
Nuclei Black/ brown
Methylene Blue (MB) Nuclei Purple Cellular organization
69
Connective tissue Blue
Lipid Red
Cytoplasm Pink
Safranin O/FastGreen (Saf O/FG) Nuclei Black Cartilage
13, 78Cytoplasm/ protein Blue/ green
GAG, mucin, mast cells Red/ orange
Toluidine blue (TB) Nuclear region Dark blue Bone or cartilage
32Cytoplasm Light blue
Mast cells Purple
Van Gieson (VG) Nuclei Blue Collagen and connective tissue
74Collagen Red
Cytoplasm/fibrin Yellow
von Kossa (VK) Phosphate and carbonate 
deposits
Black/ dark brown Mineralization 34
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